Nov 4, 10:45 AM ET
CRH plc said its subsidiary CRH America Finance, Inc. has started cash tender offers for Arcosa, Inc. notes and exchange offers for up to $1.0 billion of new CRH America Finance notes, following CRH's acquisition of Arcosa completed October 23, 2026. Arcosa is also soliciting consents to amend the indentures governing those notes, which would eliminate certain covenants, restrictive provisions, events of default and guarantee provisions. The offers are conditioned on proceeds from a concurrent public offering of senior debt by CRH America Finance, guaranteed by CRH plc, and the filing describes this as a refinancing of acquired debt rather than a change in operating results.
- Tender offers cover $400 million of 4.375% notes due 2029 and $600 million of 6.875% notes due 2032
- Early tender deadline is November 18, 2026; early settlement expected November 20, 2026; offers expire December 4, 2026
- Total tender consideration is $983.75 (2029 notes) and $1,035.00 (2032 notes) per $1,000 principal, including a $50 early tender premium
- Exchange offers are capped at up to $1,000,000,000 aggregate principal of new CRH America Finance notes guaranteed by CRH plc
Read the filing on SEC.gov ↗
Oct 29, 7:41 AM ET
CRH reported third quarter 2026 total revenues of $11.4 billion and net income of $1.2 billion, representing a decrease from the prior year due to impairment losses. The company lowered its full-year 2026 guidance for net income and adjusted EBITDA, citing a challenging residential market and inflationary costs, while announcing a new $6 billion share buyback program running through 2030. Additionally, CRH completed its $8.5 billion acquisition of Arcosa on October 23, 2026.
- Total revenues for Q3 2026 were $11.4 billion, up 3% year-over-year, while net income declined to $1.2 billion.
- Full-year 2026 guidance was revised to net income of $3.1 billion to $3.3 billion and Adjusted EBITDA of $7.8 billion to $8.0 billion.
- CRH completed the $8.5 billion acquisition of Arcosa on October 23, 2026.
- A new share buyback program of up to $6 billion was authorized, expiring at the end of 2030.
Read the filing on SEC.gov ↗
Oct 23, 8:51 AM ET
CRH announced on October 23, 2026 that it has completed its acquisition of Arcosa, Inc., a U.S. aggregates and critical infrastructure provider, for a total enterprise value of approximately $8.5 billion. The company said it will provide updated full-year 2026 guidance reflecting the deal with its third-quarter results on October 29.
- Total enterprise value of approximately $8.5 billion, as stated in the press release.
- Agreement to acquire Arcosa was first announced on June 22, 2026.
- CRH will issue updated full-year 2026 guidance reflecting the acquisition with third-quarter results on October 29.
- The filing furnishes the press release as Exhibit 99.1 under Item 7.01 and does not include new financial results.
Read the filing on SEC.gov ↗
Jul 30, 6:05 AM ET
CRH reported second quarter 2026 results with total revenues of $10.8 billion, up 6% from the prior year, and net income of $1.5 billion, up 13%. The company reaffirmed its full-year 2026 guidance for net income, Adjusted EBITDA and diluted EPS, and said it has not started a new share buyback tranche while the $8.5 billion Arcosa acquisition is pending.
- Q2 2026 diluted EPS was $2.21, up from $1.94 in Q2 2025; Adjusted EBITDA was $2.6 billion, up 7%.
- Q2 net income included gains on divestitures; income tax expense rose to $661 million from $425 million.
- 2026 guidance reaffirmed: net income $3.9 billion to $4.1 billion, Adjusted EBITDA $8.1 billion to $8.5 billion, diluted EPS $5.60 to $6.05.
- Capital expenditure guidance was lowered to $2.7 billion to $2.9 billion from $2.8 billion to $3.0 billion; no new buyback tranche has started since the Arcosa agreement on June 22, 2026.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.